Jesse C. Nussbaum

Open-label Phase 1 study to evaluate drug-drug interactions between ulonivirine and islatravir in adults without HIV

ABSTRACT Ulonivirine is a non-nucleoside reverse transcriptase inhibitor in clinical development for once-weekly oral treatment of HIV-1 in combination with islatravir. This open-label, 3-period, Phase 1 study (MK-8507-016, NCT06619678) in adults without HIV evaluated the potenti...